Shubing Jia

Shenyang Pharmaceutical University — China

Medicine · Health Sciences

5h-index82citations10works0.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pain Management and Opioid Use(2), Glioma Diagnosis and Treatment(1), Breast Cancer Treatment Studies(1), Pain Mechanisms and Treatments(1), Epigenetics and DNA Methylation(1)

Publications10 total

A novel risk-scoring model for predicting cancer-specific mortality and instituting chemotherapy in elderly patients with esophageal cancer
Diseases of the Esophagus·2025
Molecular Imaging of B7–H3–Targeting Bispecific T Cell–Engaging Antibody MGD009 in Glioblastoma Models
ACS Applied Materials & Interfaces·2025· 1 cited
Factors associated with the onset and survival of subsequent primary breast cancer in female non‐metastatic breast cancer survivors
Precision Medical Sciences·2024Open Access
Research focus and thematic trends of transient receptor potential vanilloid member 1 research: a bibliometric analysis of the global publications (1990–2023)
Naunyn-Schmiedeberg s Archives of Pharmacology·2023· 1 cited
Butein, a potential drug for the treatment of bone cancer pain through bioinformatic and network pharmacology
Toxicology and Applied Pharmacology·2023· 9 citedOpen Access
Butein, a potential drug for the treatment of Bone Cancer Pain through bioinformatic and network pharmacology
2022Open Access
An optimized herbal combination for the treatment of liver fibrosis: Hub genes, bioactive ingredients, and molecular mechanisms
Journal of Ethnopharmacology·2022· 31 cited
Analysis of CFTR gene expression as an immunological and prognostic biomarker in pan-cancers
Computers in Biology and Medicine·2022· 14 cited
Adaptive carbon ion radiotherapy for locally advanced non‐small cell lung cancer: Organ‐sparing potential and target coverage
Medical Physics·2022· 8 citedOpen Access
Incretin mimetics and sodium-glucose co-transporter 2 inhibitors as monotherapy or add-on to metformin for treatment of type 2 diabetes: a systematic review and network meta-analysis
Acta Diabetologica·2020· 18 cited

Frequent Co-authors

Rongwu Xiang(8), Yijia Xu(4), Mingyi Zhao(3), Mingyi Zhao(3), Xin Liu(2), Jingyu Yang(2), Jinghai Zhang(2), Xin Liu(2), Shangfeng Zhao(2), Qianqian Zhao(2), Yiwei Chen(2), Qianqian Zhao(1), Jinwei Bai(1), Yiwei Chen(1), Shangfeng Zhao(1), Guixia Ling(1), Fei Zhai(1), Zhiying Wang(1), Ruobing Han(1), Zinv Zhang(1)